The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of the Quad wild type arm of the AGITG ICECREAM study: A randomised phase II study of cetuximab alone or in combination with irinotecan in patients with refractory metastatic colorectal cancer with no mutations in KRAS, NRAS, BRAF or PIK3CA.
 
Jeremy David Shapiro
Research Funding - Merck Serono (Inst)
 
Subotheni Thavaneswaran
Travel, Accommodations, Expenses - Roche/Genentech
 
Craig Underhill
Research Funding - Merck (Inst)
 
Kristy Pamela Robledo
No Relationships to Disclose
 
Christos Stelios Karapetis
Consulting or Advisory Role - Merck
 
Fiona Lee Day
No Relationships to Disclose
 
Louise M. Nott
No Relationships to Disclose
 
Michael Jefford
No Relationships to Disclose
 
Lorraine A. Chantrill
Consulting or Advisory Role - Baxalta
Travel, Accommodations, Expenses - Roche
 
Nick Pavlakis
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Merck Serono; Novartis; Pfizer; Roche; Specialised Therapeutics
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Merck Serono; Novartis; Pfizer; Roche; Specialised Therapeutics
 
Niall C. Tebbutt
Honoraria - Amgen; Roche
Consulting or Advisory Role - Amgen; Roche
Travel, Accommodations, Expenses - Roche
 
Timothy Jay Price
Consulting or Advisory Role - Amgen (Inst); Merck Serono (Inst); Roche (Inst)
 
Mustafa Khasraw
Honoraria - Merck Serono
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Lilly
Research Funding - Abbvie (Inst); Merck Serono (Inst); Specialised Therapeutics (Inst)
 
Guy A. Van Hazel
No Relationships to Disclose
 
Paul Michael Waring
Employment - Roche
Leadership - Roche
Honoraria - Amgen; AstraZeneca; Foundation Medicine; Merck; Novartis; Roche
Consulting or Advisory Role - AstraZeneca; Roche
Research Funding - Roche
Patents, Royalties, Other Intellectual Property - Roche
Travel, Accommodations, Expenses - Roche
 
Sabine Tejpar
Honoraria - Merck Serono; Regeneron
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Merck Serono; Regeneron; Roche/Genentech
Speakers' Bureau - Merck Serono; Roche; Sanofi
Research Funding - Merck Serono (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Merck Serono; Roche; Sanofi
 
John Simes
No Relationships to Disclose
 
Val Gebski
Honoraria - Sirtex Medical
Consulting or Advisory Role - Sirtex Medical
Travel, Accommodations, Expenses - Sirtex Medical
 
Jayesh Desai
Honoraria - Amgen; GlaxoSmithKline; Novartis
Consulting or Advisory Role - Amgen; Bionomics; Lilly; Novartis; Plexxikon
Research Funding - Bionomics (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Roche (Inst)
 
Eva Segelov
Consulting or Advisory Role - Bayer; Ipsen; Pfizer; Roche
Research Funding - Ipsen (Inst); Merck Serono (Inst)
Travel, Accommodations, Expenses - Ipsen; Roche